MRE11 and cancer: In papillary thyroid carcinoma (PTC), the downregulation of MRE11 and RAD50 expression, through the lncRNA SLC26A4-AS1-mediated disruption of the DDX5-E2F1 transcription factor complex, inhibits the invasion and metastasis capability of cancer cells [124].